All In Biotech

Drug Trial Radar · NCT06801834

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

A Global, Multicenter, Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Standard of Care (SOC) in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 695 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

695

Planned (sponsor's estimate)

Start

Apr 4, 2025

Primary completion

Oct 2029

Study completion Oct 2029

Sponsor

Lead sponsor
Gilead SciencesGilead Sciences (GILD)
Sponsor type
Industry
First posted
Jan 30, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical study is to learn more about the study drug sacituzumab govitecan (SG; Trodelvy®; GS-0132; IMMU 132), versus standard of care (SOC) in participants with previously treated extensive stage small cell lung cancer (ES-SCLC). The primary objectives of this study are to compare the effect of SG to SOC on overall survival (OS).

Conditions

  • Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Interventions

  • Sacituzumab Govitecan (SG)Drug

    Administered intravenously

  • TopotecanDrug

    Administered intravenously

  • Amrubicin (Japan only)Drug

    Administered intravenously

  • Lurbinectedin (regions/countries where approved and available)Drug

    Administered intravenously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Survival (OS)Time frame: Up to 4.5 years

Locations

219 sites in 23 countries. Site status is shown where the registry gives one.

  • Alaska Oncology and Hematology

    Anchorage, Alaska · Recruiting

  • Genesis Cancer and Blood Institute

    Hot Springs, Arkansas · Recruiting

  • Los Angeles Cancer Network

    Anaheim, California · Recruiting

  • Boca Raton Regional

    Miami, Florida · Recruiting

  • Hope and Healing Cancer Services

    Hinsdale, Illinois · Recruiting

  • Southern Illinois University School of Medicine

    Springfield, Illinois · Recruiting

  • Springfield Clinic

    Springfield, Illinois · Recruiting

  • Parkview Research Center

    Fort Wayne, Indiana · Recruiting

  • IU Health Ball Memorial Hospital and Physicians - Cancer Center - Muncie

    Muncie, Indiana · Recruiting

  • Northwest Cancer Centers

    Dyer, Kentucky · Recruiting

  • St. Claire Regional Medical Ce

    Morehead, Kentucky · Recruiting

  • New Mexico Oncology Hematology Consultants, Ltd

    Albuquerque, New Mexico · Recruiting

  • University Hospitals Seidman Cancer Center

    Sandusky, Ohio · Recruiting

  • Taylor Cancer Research Foundation

    Toledo, Ohio · Recruiting

  • Spoknwrd Clinical Trials Inc.

    Easton, Pennsylvania · Recruiting

  • Hendrick Health System

    Abilene, Texas · Recruiting

  • MD Anderson Cancer Center

    Houston, Texas · Recruiting

  • Texas Oncology - San Antonio

    New Braunfels, Texas · Recruiting

  • The University of Texas Health Science Center at Tyler

    Tyler, Texas · Recruiting

  • Gundersen Health System

    West Salem, Wisconsin · Recruiting

  • Hospital Britanico de Buenos Aires

    Buenos Aires, Argentina · Recruiting

  • Universidad de Buenos Aires - Facultad de Medicina - Instituto Alexander Fleming (Buenos Aires)

    Buenos Aires, Argentina · Recruiting

  • Clinica Colon S.A.A (Clinica y Maternidad Colon) Investigaciones Clinicas de Mar del Plata

    Buenos Aires, Argentina · Recruiting

  • Centro Oncologico de Excelencia (San Juan)

    San Juan, Argentina · Recruiting

  • Centro Médico San Roque

    San Miguel de Tucumán, Argentina · Recruiting

  • Sanatorio Parque SA

    Santa Fe, Argentina · Recruiting

  • Cancer Care Wollongong

    New South Wales, New South Wales, Australia · Recruiting

  • Metro North HHS (The Prince Charles Hospital)

    Queensland, Queensland, Australia · Recruiting

  • Gold Coast University Hospital

    Southport, Queensland, Australia · Recruiting

  • Cancer Research SA

    Adelaide, South Australia, Australia · Recruiting

  • St Vincent's Hospital Melbourne

    Fitzroy, Victoria, Australia · Recruiting

  • Sir Charles Gairdner Hospital

    Nedlands, Western Australia, Australia · Recruiting

  • Grand Hopital de Charleroi

    Charleroi, Belgium · Recruiting

  • Jessa Ziekenhuis

    Hasselt, Belgium · Recruiting

  • Centre Hospitalier Universitaire de Liege Avenue de Lhopital 1

    Liège, Belgium · Recruiting

  • AZ Delta

    Roeselare, Belgium · Recruiting

  • Vitaz

    Sint-Niklaas, Belgium · Recruiting

  • Instituto do Cancer do Ceara

    Fortaleza Ceara, Brazil · Recruiting

  • Hospital de Caridade de Ijui

    Ijuí, Brazil · Recruiting

  • Liga Norte-Rio-Grandense Contra o Cancer - Pesquisa Clinica

    Natal, Brazil · Recruiting

Showing 40 of 219 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.